Paul Tudor Jones’s Sight Sciences SGHT Stock Holding History

Paul Tudor Jones’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,692	Closed	-$413K	–	2477
2022 Q1	$413K	Sell	35,692 -10,667	-23%	-$164K	0.01%	1382
2021 Q4	$815K	Buy	+46,359	New	+$1.02M	0.01%	1136

Other funds holding SGHT

DCP

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Paul Tudor Jones's SGHT Position: Q2 2022 in Review

Paul Tudor Jones sold out of Sight Sciences (SGHT) in Q2 2022, closing a stake of 35,692 shares — an estimated $413K sold.

Paul Tudor Jones first reported a position in SGHT in Q4 2021 and held it in 2 quarters. The position peaked at $815K in Q4 2021. 68 funds tracked by Wall St. Rank hold SGHT as of Q2 2022.

Paul Tudor Jones reported no remaining Sight Sciences position as of Q2 2022 after selling out during the quarter.
Paul Tudor Jones sold 35,692 Sight Sciences shares in Q2 2022, an estimated $413K.
Paul Tudor Jones first reported a position in Sight Sciences in Q4 2021 and held it in 2 quarters.
Paul Tudor Jones's Sight Sciences position peaked at $815K in Q4 2021.
68 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2022.

Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.